Paper Titles

Nano-Calcium Phosphate/PLLA Incorporated with bFGF as In Situ-Transplantable Carrier for Cartilage Regeneration
p.953

Mechanical Behavior of Complex 3D Calcium Phosphate Cement Scaffolds Fabricated by Indirect Solid Freeform Fabrication In Vivo
p.957

Blood Permeability of a Novel Ceramic Scaffold for BMP-2
p.961

BMP-2 Dose-Response and Release Studies in Functionally Graded HAp
p.965

The Degradation Rate and Osteoinductive Efficacy of BMP-2-Bearing Biomimetic Coatings Vary as a Function of the Drug Delivery Mode
p.969

Controlled Release of rhBMP-2 Loaded Poly(DL-lactic-co-glycolic Acid)/ Calcium Phosphate Cement Composites In Vivo
p.973

In Vivo Evaluation of Porous Hydroxyapatite/Collagen Composite as a Carrier of OP-1 in a Rabbit PLF Model
p.977

Anorganic Bone Mineral Coated with Tetra-Cell Adhesion Molecule Enhances Bone Formation in Rabbit Calvarial Defects
p.981

Evaluation of 5% Na₂O-Incorporated Calcium Metaphosphate as a Scaffold for Tissue-Engineered Bone Regeneration
p.985

HomeKey Engineering MaterialsKey Engineering Materials Vols. 309-311The Degradation Rate and Osteoinductive Efficacy...

The Degradation Rate and Osteoinductive Efficacy of BMP-2-Bearing Biomimetic Coatings Vary as a Function of the Drug Delivery Mode

Article Preview

Abstract:

You might also be interested in these eBooks

Bioceramics 18

Info:

Periodical:

Key Engineering Materials (Volumes 309-311)

Pages:

969-972

DOI:

https://doi.org/10.4028/www.scientific.net/KEM.309-311.969

Citation:

Cite this paper

Online since:

May 2006

Authors:

Yue Lian Liu, R.O. Huse, K. de Groot, Daniel Buser, E.B. Hunziker

Keywords:

Biomimetic, BMP-2, Calcium Phosphate, Coating, Delivery Mode, Implant, Osteoinductive

Export:

RIS, BibTeX

Price:

Permissions CCC:

Request Permissions

Permissions PLS:

Request Permissions

Сopyright:

© 2006 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

[1] Jansen J.A., Vehof J.W.M., Ruhé P.Q., Kroeze-Deutman H., Kuboki Y., Takita H., Hedberg E.L. and Mikos A.G. J Control Release, 2005 101(1-3):127-36.

DOI: 10.1016/j.jconrel.2004.07.005

[2] Hollinger J.O., Leong K., Biomaterials, 1996; 17:187-194.

[3] Ono I., Gunji H, Kaneko F., Saito T., and Kuboki Y. J Craniofac Surg, 1995; 6(3):238-44.

[4] Kirker-Head C.A. Adv Drug Deliv Rev, 2000; 43:65

[5] Liu Y., Hunziker E. B., de Groot K., Bone, 2005; 36: 745-757.

[6] Liu Y., Hunziker E. B., Van de Vaal C., de Groot K., Bioceramics, 2003; 16: 619-622. 0 2 4 6 8 10 12 14 16 18

[2] 5µg 5.0µg 7.5µg Amount of BMP-2 adsorbed (µg/implant) 1 week 2 weeks 3 weeks